Our consultants

Dr Wale Atoyebi is Consultant Haematologist at Oxford University Hospitals and Honorary Senior Clinical Lecturer at University of Oxford.

His basic and specialist haematology training was in Oxford. His main interest is in red cell disorders.

He sits on the NHS England Clinical Reference Group for Haemoglobinopathies and is co-author of UK Standards of Care for adults with Sickle Cell Disease.

He is also involved in collaborative research focused on strengthening healthcare systems by improving best practice in the diagnostics and management of sickle cell disease in Sub-Saharan Africa.

Dr Chowdhury studied undergraduate medicine in Cambridge before completing her clinical training in Oxford. Her specialist haematology training was undertaken at University College, London and Oxford University Hospitals.

She joined the Weatherall Institute for Molecular Medicine in 2010, undertaking a Wellcome Trust DPhil Fellowship, characterising and targeting the stem cells which drive myelodysplastic syndromes. She has been awarded an MRC Clinical Academic Partnership to improve the diagnosis of myeloid diseases.

She looks after patients with myeloid diseases and is clinical lead for the Flow Cytometry Service.

Dr Collins trained in medicine at Cambridge and St Bartholomew's and the Royal London Hospitals. His specialist haematology training was in Oxford.

Dr Collins sits on the high grade and Hodgkin lymphoma national study groups and is also a member of the lymphoma guidelines development group of NICE. He co-authored the national guidelines for relapsed Hodgkin Lymphoma. He is also a trustee of the national Lymphoma Association.

Associate Professor of Haematology, MRC CARP Fellow, University of Oxford

Nikki Curry is a Consultant Haematologist at the Oxford Haemophilia and Thrombosis Centre (OHTC). Her clinical interests cover the care of patients with inherited and acquired bleeding and thrombotic disorders, including the care of women with these disorders during pregnancy.

She is Co-Chair of the UKHCDO Gynaecology Working Party, and they have recently completed guidelines around the management of the care of gynaecological issues for women with inherited bleeding disorders.

Dr Curry is currently the clinical lead for VTE Prevention. Her main research interest is in the treatment of acquired coagulopathy, in particular traumatic coagulopathy and the role of early fibrinogen replacement, and means of guiding therapy during active major haemorrhage and she has more recently secured an MRC fellowship to study the role of the endothelium in the development of coagulopathy.

Dr Desborough is a Consultant Haematologist subspecialising in immunohaematology, obstetric haematology and transfusion medicine.

He trained in medicine at the University of Sheffield. He did his specialist training in Oxford and doctoral and post-doctoral research at the University of Oxford.

Dr Desborough is the consultant lead for transfusion medicine in Oxford and is lead for the Thames Valley and Wessex highly specialised Thrombotic Thrombocytopenic Purpura (TTP) Service.

Dr Hay qualified in medicine at Oxford, and undertook her postgraduate training in Oxford, London and Glasgow.

She now works mainly for Oxford's Clinical Medical School, where she is responsible for education in pathology and laboratory medicine disciplines.

As an honorary consultant haematologist, she focuses on the care of patients with haemoglobin disorders and on laboratory diagnostics.

Consultant Haematologist

Dalia has been the Director of the Haemophilia Centre since September 2023 and completed her Haematology training in Oxford and undergraduate studies in Cambridge.

She is also the Clinical Lead for Anticoagulation and Haemostasis Genomics at Oxford University Hospitals.

As part of her role, she leads the Anticoagulation Optimisation Service with primary care and has done so since 2020.

Dalia co-chairs the Thames Valley Regional Complex Thrombosis MDT, organises the South and Central GLH Haemostasis Genomics MDT and is an active member of the Thames Valley Venous Network and MDT. She regularly attends the High-Risk Obstetric MDT.

She has a keen interest in issues that affect women with bleeding disorders and cancer associated thrombosis, having undertaken a period of research at the Oxford Centre for Translational Myeloma Research looking at platelet reactivity in patients with plasma cell disorders.

Dr Kothari completed undergraduate studies at the University of Cambridge, before attending medical school at Brasenose College, Oxford.

After qualification he trained in clinical haematology at University College Hospital ,London, focusing on the comprehensive management of lymphoid malignancies.

He also spent two years working on the early-phase development of monoclonal antibodies for Non-Hodgkin lymphomas. As a consultant in Oxford he works across the lymphoma and plasma cell dyscrasia services and is clinical lead for the late phase clinical trial group.

Dr Mead trained in medicine at Oxford, and trained in haematology at St Bartholomew's Hospital and University College London.

His 2007 PhD focused on the biology of myeloid leukaemias. His specialist interest is clinical and basic research into myeloid disorders, and he runs a research group at the Weatherall Institute of Molecular Medicine (WIMM) focused on myeloid diseases and normal blood stem cell biology.

Adam Mead - Radcliffe Department of Medicine

Mike Murphy is Professor of Transfusion Medicine at the University of Oxford and is Consultant Haematologist for NHS Blood and Transplant (NHSBT) and Oxford University Hospitals. He studied medicine and completed his haematology training at St Bartholomew's Hospital, and became a Senior Lecturer in Haematology there in 1985. In 1996, he moved to Oxford and in 2004 became Professor of Blood Transfusion Medicine.

The work done by he and his colleagues using technology to improve the safety and effectiveness of transfusion practice has won numerous national awards and is an exemplar for the NHS QIPP initiative. He co-founded the NHSBT Clinical Studies Unit, its Systematic Reviews Initiative and the Transfusion Evidence Library.

Dr Pawson is Consultant in Haematology and Transfusion Medicine, NHS Blood and Transplant, and Honorary Consultant, Honorary Senior Clinical Lecturer, University of Oxford.

She has been part of OUH since October 2001, and is a consultant in the NHSBT Oxford Stem Cell and Immunotherapy (SCI) Laboratory and Therapeutic Apheresis Service, managing patients undergoing stem cell and lymphocyte collections, extracorporeal photopheresis and other apheresis procedures.

She is also Acting Medical Director of the British Bone Marrow Registry and NHS Cord Blood Bank, and part of the OUH Blood and Marrow Transplant team, seeing patients in the post-transplant outpatient clinic and undertaking counselling and medical assessment of family donors.

Dr Sue Pavord is Consultant Haematologist and Director of Haematology Laboratories at Oxford University Hospitals.

She is Senior Lecturer in Medicine at St Edmund Hall, University of Oxford and is serving Vice President and President elect of the British Society for Haematology.

She has been a pioneer in the development of obstetric haematology as a subspecialty; establishing services for management of iron deficiency; defining VITT as a new syndrome; and securing upfront treatments for immune haematology conditions during the COVID-19 pandemic.

She was awarded national clinical practitioner in the 2020 Healthcare Quality Improvement Partnerships.

Her research interests complement her clinical work, and she has over 200 publications in haematology, including the leading textbook in obstetric haematology.

Dr Peniket trained in medicine in Oxford and Cambridge before working in bone marrow transplantation in London. As a consultant in Oxford he has worked with leukaemia, myeloma and transplant patients.

He is Clinical Director of Haematology and Bone Marrow Transplantation in Oxford and Chair of the British Society of Bone Marrow Transplantation Clinical Trials Committee. He is also a member of the national Clinical Reference Groups both for bone marrow transplantation and chemotherapy.

Karthik Ramasamy is a Consultant Haematologist at Oxford University Hospitals and Associate Professor of Haematology, NDORMS, University of Oxford, UK.

Dr Ramasamy is the Clinical Director of the Oxford Myeloma Translational Research Centre. His clinical interest is providing care for patients with plasma cell dyscrasias (MGUS, AL Amyloidosis, Myeloma).

He is the Divisional Lead for Cancer Research for National Institute for Health Research (NIHR), Clinical Research Network Thames Valley and South Midlands, UK. Dr Ramasamy completed his haematology training in London.

Karthik Ramasamy - Radcliffe Department of Medicine

Dr Noémi Roy trained in medicine in Edinburgh and carried out her haematology training in London and Oxford. Her main interests are haemoglobinopathies and rare inherited anaemias, and in particular the genetic investigation of inherited anaemias, including whole genome sequencing.

She is also involved in investigating the management of iron deficiency in diverse patient groups. She is dedicated to using patients' views to guide how research in conducted in haematology and coordinating best practice care in red cell disorders at the European level.

Professor Anna Schuh is Director of Molecular Diagnostics at the University of Oxford and an Honorary Consultant Haematologist.

She has participated as a principal or chief investigator in over 30 early or late phase clinical trials in chronic lymphocytic leukaemia. A number of these led to subsequent NICE approvals and have changed clinical practice in the UK and worldwide.

Her primary research interest is with the development, evaluation and implementation of new technologies for precision diagnostics with a particular focus on genomics.

Dr Shapiro is a Consultant Haematologist based at the Oxford Haemophilia and Thrombosis Centre and an Associate Professor of Haematology at the University of Oxford.

She works entirely in the field of haemostasis and thrombosis: haemophilia and other bleeding disorders, thrombosis and anticoagulation. She has particular interest in improving patient safety, with projects to optimise anticoagulation winning national awards; and in improving knowledge of aging and comorbidities in haemophilia including with respect to new innovative treatments.

She is the National Speciality Advisor to NHSE for Specialised Blood Disorders (2022 - ) and Co-Chair of the Scientific SubCommittee on FVIII, FIX and Rare Coagulation Disorders for the International Society of Thrombosis and Haemostasis (2022-). Her research interests complement her clinical work.

Prof Simon Stanworth - NHSBT

Prof Vyas is Professor of Haematology and Consultant Haematologist in myeloid disorders. He studied medicine at Cambridge and Oxford, and, after general medical training in London, he completed a PhD on the control of gene regulation with Prof Doug Higgs and Prof Sir David Weatherall at the MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine (WIMM).

His long-term interest is understanding the molecular basis of haematological disease, and he runs a research laboratory in the MRC Molecular Haematology Unit.

Dr Willan holds an undergraduate degree from Cambridge, before training in medicine at Oxford, from where he also holds a DPhil in genetics.

He works as a general haematologist, both in Oxford and at Wexham Park Hospital.

In addition to his clinical roles, he undertakes research, and has various teaching roles, including as Fellow of Clinical Medicine at Brasenose College, Oxford.